Skip to main content

View full-text article in PMC

. 2020 Feb 23;29:105325. doi: 10.1016/j.dib.2020.105325

Table 1.

Effect of HML on vital organs in tumor-bearing mice. (mean ± SD, n = 5).

Group	Dose (mg/kg)	Organ index
Group	Dose (mg/kg)	Spleen index	Liver index	Renal index
Non-tumor	–	0.36 ± 0.09	4.65 ± 0.63	1.41 ± 0.22
DMSO	–	3.16 ± 0.25^a	7.38 ± 0.68^a	1.42 ± 0.20
HML	10	2.78 ± 0.26^a	6.42 ± 0.82^a	1.37 ± 0.24
HML	20	2.62 ± 0.19^a	6.33 ± 0.70^a^,	1.40 ± 0.19
CDDP	5	2.94 ± 0.24^a	7.69 ± 1.08^a	1.31 ± 0.38^a^,^b

^a

P < 0.05, compared to non-tumor group.

^b

P < 0.05, compared to DMSO-treated group.